VU University Medical Center (VUmc)/Academic Centre for Dentistry Amsterdam (ACTA), Department of Oral & Maxillofacial Surgery/Oral Pathology, Amsterdam, The Netherlands.
Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17(1):e76-82. doi: 10.4317/medoral.18006.
The aim of the present study is to examine all cases of intraosseous benign ameloblastomas treated between 1970 and 2010 in a single institution and to look for a possible correlation between the histopathological aspects and the demographical and clinical parameters, as well as the treatment outcome. The data of a total number of 44 patients were retrieved from the records. Nine patients were excluded because of doubt about the correct diagnosis (8 patients) or because of an extra-osseous presentation (1 patient). No statistically significant differences were found between the histopathological (sub)types of ameloblastomas and the demographical and clinical parameters, nor between the histopathological (sub)types and treatment outcome. Of the 28 patients treated by enucleation, in 17 patients one or more recurrences occurred, with no significant predilection for any histopathological (sub)type, including the unicystic type. There were no significant differences in the recurrence rate after enucleation in patients below and above the age of 20 years either. In six out of 17 patients with a recurrence, the recurrent lesion showed a different histopathological subtype than was encountered in the primary. In two cases a change from solid/multicystic to desmoplastic ameloblastomas was noticed. In conclusion, the current histopathological classification of benign intraosseous ameloblastoma does not seem to have clinical relevance with the possible exception of the luminal unicystic ameloblastoma that has been removed in toto, unfragmented. Since no primary desmoplastic ameloblastomas were encountered in the present study no further comments can be made on this apparently rare entity.
本研究旨在检查 1970 年至 2010 年间在单一机构治疗的所有骨内良性成釉细胞瘤病例,并寻找组织病理学特征与人口统计学和临床参数之间以及治疗结果之间的可能相关性。从记录中检索到 44 名患者的资料。9 名患者因对正确诊断有疑问(8 名患者)或因骨外表现(1 名患者)而被排除在外。在成釉细胞瘤的组织病理学(亚型)与人口统计学和临床参数之间,以及在组织病理学(亚型)与治疗结果之间,未发现统计学上的显著差异。在通过剜除术治疗的 28 名患者中,有 17 名患者发生了一次或多次复发,任何组织病理学(亚型)均无明显倾向,包括单囊型。在 20 岁以下和以上的患者中,剜除术后的复发率也没有显著差异。在 17 例复发患者中,有 6 例复发病灶的组织病理学亚型与原发性不同。在两种情况下,从实体/多腔型到促结缔组织增生型成釉细胞瘤的变化被注意到。总之,目前的骨内良性成釉细胞瘤的组织病理学分类似乎没有临床相关性,可能除了完整切除、无碎片的腔型单囊型成釉细胞瘤。由于在本研究中未遇到原发性促结缔组织增生型成釉细胞瘤,因此无法对这一明显罕见的实体进行进一步评论。